EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The Challenges and Opportunities of Translational Pathology

Lanjing Zhang iD

Journal of Clinical and Translational Pathology · 2022

DOI: 10.14218/jctp.2022.00001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical and Translational Pathology, 2022. Verfasst von Lanjing Zhang. Beteiligte Einrichtung: Department of Pathology, Princeton Medical Center, Plainsboro, NJ, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Translational pathology has not caught up with the quality and quantity of translational medicine. Thus, challenges and opportunities related to translational pathology are discussed here. Pathologists should actively participate in reverse translational research that seeks mechanistic insights to explain clinical findings and/or solve clinical problems. Challenges in translational pathology include ambiguity in defining translational pathology, pathologists' mindsets about translational research, lack of sufficient workforce and immature publication outlets. However, with collective wisdom and support of various stakeholders, we can expand the pool of pathologist scientists, build a translational pathology community and drive innovations in medicine through computational, molecular genetic/genomic and digital pathology approaches.

Schlagwörter

Stichwörter der Autor:innen

OmicsTranslational medicineTranslational pathologyclinical and translational research award

Autor:innen und Institutionen

  • Department of Pathology, Princeton Medical Center, Plainsboro, NJ, USA.
  • Department of Biological Sciences, Rutgers University Newark, NJ, USA.
  • Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
  • Department of Chemical Biology, Rutgers Ernest Mario School of Pharmacy, Piscataway, NJ, USA.

ORCID-Profile: Lanjing Zhang

Förderung

  • NCI NIH HHS

Zitieren

APA

Zhang, L. (2022). The Challenges and Opportunities of Translational Pathology. Journal of Clinical and Translational Pathology. https://doi.org/10.14218/jctp.2022.00001

Vancouver

Zhang L. The Challenges and Opportunities of Translational Pathology. Journal of Clinical and Translational Pathology. 2022. doi:10.14218/jctp.2022.00001

BibTeX
@article{Zhang2022,
  author = {Zhang, Lanjing},
  title = {The Challenges and Opportunities of Translational Pathology},
  journal = {Journal of Clinical and Translational Pathology},
  year = {2022},
  doi = {10.14218/jctp.2022.00001}
}
Kostenlos starten →